Call 888-776-0942 from 8 a.m. to 10 p.m. Eastern Time
New York, November 19, 2021/PRNewswire/-Dietary supplement products are now part of a rapidly growing market. Part of the increase in demand for such products is due to people's increasing attention to health and fitness. In addition, the increased demand for supplements in the sports industry may have a positive impact on the market's profitability level over the projected time span. The supplement market includes various market segments, including sports foods, medicinal supplements, and other supplements, depending on the use. As the value of the global sports industry continues to increase, sports nutrition is expected to become the fastest growing part of the market in the next few years. Moreover, according to data provided by Facts & Factors, the global dietary supplement market in 2019 is estimated to be 167.8 billion U.S. dollars, and it is expected to reach a record high of 306.8 billion U.S. dollars by 2026, with a compound annual growth rate of 9%. Todos Medical Ltd. (OTCQB: TOMDF), Herbalife Nutrition Co., Ltd. (NYSE: HLF), Sprouts Farmers Market, Inc. (NASDAQ: SFM), Nu Skin Enterprises (NYSE: NUS), Unilever (NYSE: UL))
Of course, another factor that has played a role in the development of the supplement market is the pandemic. Since the pandemic has spread in the United States and around the world, the need for alternative healthcare options has become obvious. Therefore, new technologies and innovations will continue to play an important role in the development of drugs and treatments in the coming years. For example, the telemedicine sector includes a wide range of technical fields under its umbrella. Specifically, technologies such as telemedicine, robots, and chatbots are being deployed to help gather information, comfort the people, treat patients, make diagnoses, and even prepare future vaccines.
Todos Medical Ltd. (OTCQB: TOMDF) announced breaking news yesterday, “It has cooperated with T-Cell Protect Hellas SA (T-Cell Protect) on the basis of its Tollovid® and Tollovid Daily™ 3CL protease inhibitors and immune support dietary supplements. The product will be sold in 30 European countries/regions under the T-Cell Protect brand, and the agreement requires at least 500,000 bottles to be sold within 18 months. More information about this product can be found on www.tcellprotect.com. According to the terms of the agreement, T-Cell Protect will purchase finished products from Todos in wholesale until T-Cell Protect establishes manufacturing capacity in its currently operating plant in Greece to support the European market. At that time, Todos will pay for the licensed products produced by T-Cell Protect. Sales received double-digit royalties. The company expects revenue to increase starting from this agreement beginning this quarter.
At the same time as this announcement, T-Cell Protect has invested 1 million euros in Todos Medical to support the clinical development of the company's 3CL protease inhibitor antiviral drug candidate Tollovir, and will obtain Tollovir's exclusive marketing rights in Greece. T-Cell Protect intends to initiate Tollovir's conditional emergency use authorization process to meet the growing demand for the prevention and treatment of coronavirus (including COVID-19).
Themis Filippopoulos, President and CEO of T-Cell Protect, said: "We are pleased to introduce this new daily dietary supplement based on the Tollovid dietary supplement formula to the European market to provide assistance to people seeking additional targeted immune support." We are very clear that we should focus on natural supplements because this is our consistent area and we believe that we can truly change the lives of people all over the world. As consumers pay more and more attention to immune support products using natural ingredients, we believe that the formula used in Tollovid products will ideally position our new T-Cell Protect supplement products to occupy the rising category of 3CL protease inhibitors Significant market share. We are also very happy to invest in the development of Tollovir, especially the recent increase in interest in 3CL protease inhibitor antiviral products. We intend to work hard with the Todos team to obtain market authorization as soon as possible.
Gerald E. Commissiong, President and CEO of Todos Medical, said: "We believe that this distribution agreement and related investment confirm our business approach to Tollovid and Tollovid Daily products." Significant progress continues to be made in this regard, and we believe that this promising treatment will have a significant impact on human health."
"We look forward to working with T-Cell Protect to bring our game-changing therapeutic product candidate Tollovir to the market to treat COVID-19 patients in Greece," said Dr. Dorit Arad, founder and chief scientific officer of Todos NLC Pharma.' 3CL Biological joint venture partner. "
Herbalife Nutrition Co., Ltd. (NYSE: HLF) announced in September that it has opened and started shipping the first orders from its newest distribution center in Hagerstown, Maryland. The new 178,000 square foot facility will help meet the growing demand for the company's nutritional products and will meet distribution needs in the eastern and northeastern regions of the United States. The facility will employ approximately 85 employees and contribute approximately US$6 million to the local economy each year. "Driven by our distributors’ years of growth in providing valuable nutritional solutions to customers across the country, our new distribution facility allows us to better serve our rapidly expanding customer base, while also creating further improvements for the company. Efficiency,” said Chief Marketing Officer Mark Schissel. Herbalife Nutrition Operations Officer.
Sprouts Farmers Market, Inc. (NASDAQ: SFM) announced earlier this year that it opened a new agricultural product distribution center in Orlando. This is its first distribution center in Florida and the nation's first. Seven distribution centers. Since opening its first store in the state in 2017, Sprouts has been expanding rapidly in Florida. The center will provide services to all 23 grocery stores currently in the state and another 10 stores planned to open in Florida this year. The 135,000-square-foot facility was built for Sprouts, including 34°F and 55°F storage rooms and fruit ripening rooms, which are perfect for the variety of fresh produce provided by Sprouts. Sprouts recently announced that it will increase the efficiency of its network of fresh distribution centers by placing them within 250 miles of the stores they serve to provide fresher local assortment. "Organic food accounts for more than one-third of our Florida agricultural products business, and we know that shoppers across the state are interested in fresh, affordable organic food and local varieties," said Chief Fresh Marketing Officer Scott Neal. "We have formed a team of local agricultural product buyers to bring the freshest local products to the market. In addition, the state-of-the-art ripening room in the new center provides an ideal climate for agricultural products storage and will immediately provide shoppers with full maturity Avocados and bananas."
Nu Skin Enterprises (NYSE: NUS) develops and distributes personal care and health products globally. Provide skin care systems, including ageLOC Me custom skin care and ageLOC Spa systems, as well as ageLOC LumiSpa skin care and cleaning equipment; and Epoch products, including plant ingredients derived from renewable resources, and a range of other cosmetics and personal care products. The company also provides ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping system, LifePak nutritional supplements, and other anti-aging nutritional solutions and weight management products.
Unilever (NYSE: UL) announced last year that it had signed an agreement to acquire SmartyPants Vitamins, a vitamin, mineral and supplement company based in the United States. SmartyPants Vitamins is headquartered in Los Angeles and was founded in 2011 by entrepreneurs Courtney Nichols Gould and Gordon Gould. They set out to develop a comprehensive supplement made of high-quality ingredients to meet the health needs of children and adults. SmartyPants Vitamins has a simple and powerful promise: smart, simple and true. SmartyPants uses non-GMO certified ingredients and a series of sustainable sources of bioavailable nutrients. Their product line does not contain synthetic colors, artificial flavors, sweeteners and preservatives.
Subscribe now! Watch our live report https://www.youtube.com/FinancialBuzzMedia
Follow us on Twitter for real-time financial news updates: https://twitter.com/financialbuzz
Follow us and chat with us on Instagram: https://www.instagram.com/financialbuzz
Like us on Facebook to receive real-time updates: https://www.facebook.com/Financialbuzz/
FinancialBuzz.com is a leading financial news information portal that aims to provide market news, investment news, personal finance, politics, entertainment, the latest trends, in-depth broadcasts of stock news, market analysis and company interviews. As a pioneer in financially driven digital space, video production and social media integration, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also through our unique media platform, including news dedicated line delivery, digital advertising, social media relations, video production, broadcasting and financial publications, to provide third parties with financial news public relations dissemination, branding, marketing and advertising to provide Corporate news and original content.
Please note: FinancialBuzz.com is not a financial advisor or advisor, investment advisor or broker-dealer, nor does it engage in any activities that require such registration. The information provided on http://www.FinancialBuzz.com (the "Website") is either original financial news or by our affiliates (sponsored content), FinancialBuzz.com (a financial news media and marketing company) [exclusive ] The provided paid advertisements sign media purchase or service agreements with companies related to articles published on the website or other editorials advertised for such companies. Unless otherwise stated, none of the companies mentioned in this editorial directly provide compensation to FinancialBuzz.com. We are not an independent news media provider and therefore do not represent or guarantee the accuracy, fairness or completeness of the information published on the website. FinancialBuzz.com charges for the production and display of high-quality and complex content and other financial news and public relations media services on FinancialBuzz.com. FinancialBuzz.com does not provide any personal opinions, suggestions or biased comments, because we purely combine public market information with financial and corporate news. FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our unique financial news line and media platform. Todos Medical ltd. For video production, filming and editing, news reporting, financial and corporate news dissemination, FinancialBuzz.com has been compensated by the company for US$5,000. Our fee may be a fixed amount of cash, it may be a negotiated amount of securities of the company described in this editorial or website, or a combination of the two. Securities are usually paid in parts, part of which is received at the time of employment, and the rest is paid at or near the end of the employment. FinancialBuzz.com will always disclose any securities compensation or cash payments for financial news PR advertisements. FinancialBuzz.com does not promise to update any information on the editorial or website or continue to publish information about any company. The information contained herein is not intended to be used as a basis for investment decisions and should not be regarded as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any securities. FinancialBuzz.com, members and affiliates are not responsible for any gains or losses arising from opinions expressed in this editorial or website, company profile, quotation, or other materials or presentations published electronically or in print. Investors are fully responsible for any and all investment decisions made based on their own independent research and assessment of their investment objectives, risk tolerance and financial status. FinancialBuzz.com. By visiting this editorial and the website and any of its pages, you agree to be bound by the terms of use and privacy policy as amended from time to time. Any content published by FinancialBuzz.com does not constitute a recommendation for any investor to buy, hold or sell any specific securities, pursue a specific investment strategy or any securities suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular securities or investment strategy is appropriate based on their goals, other securities holdings, financial needs and taxation status. You agree to consult your investment advisors, tax and legal advisors before making any investment decisions. We make no representations about the completeness, accuracy or timeliness of the materials provided. All materials are subject to change without notice. The information comes from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our complete disclaimer, disclosure and terms of use, please visit: http://www.financialbuzz.com.
Media Contact: [Email Protection] 1-877-601-1879 www.FinancialBuzz.com
More news releases on similar topics
Cision Distribution 888-776-0942 8 a.m. to 9 p.m. Eastern Time